Serkan Durdu

Serkan Durdu

Auto-generated profile, based on publicly available information

Serkan Durdu

Department of Cardiovascular Surgery, Heart Center, Ankara University School of Medicine, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2014 in Circulation
Verified
Journal Article
Closed access
PDF file
DZDeli Zhang
Deli Zhang
CWChia-Tung Wu
Chia-Tung Wu
XQXiaoYan Qi
XiaoYan Qi
RMRoelien A.M. Meijering
Roelien A.M. Meijering
FHFemke Hoogstra-Berends
Femke Hoogstra-Berends
BBBianca J.J.M. Brundel
Bianca J.J.M. Brundel
Background—: Atrial fibrillation (AF) is characterized by structural remodeling, contractile dysfunction, and AF progression. Histone deacetylases (HDACs) influence acetylation of both histones and cytosolic proteins, thereby mediating epigenetic regulation and influencing cell proteostasis. Because the exact function of HDACs in AF is unknown, we investigated their role in experimental and clinical AF models. Methods and Results—: Tachypacing of HL-1 atrial cardiomyocytes and Drosophila pupae hearts significantly impaired contractile function (amplitude of Ca 2+ transients and heart wall contractions). This dysfunction was prevented by inhibition of HDAC6 (tubacin) and sirtuins (nicotinamide). Tachypacing induced specific activation of HDAC6, resulting in α-tubulin deacetylation, depolymerization, and degradation by calpain. Tachypacing-induced contractile dysfunction was completely rescued by dominant-negative HDAC6 mutants with loss of deacetylase activity in the second catalytic domain, which bears α-tubulin deacetylase activity. Furthermore, in vivo treatment with the HDAC6 inhibitor tubastatin A protected atrial tachypaced dogs from electric remodeling (action potential duration shortening, L-type Ca 2+ current reduction, AF promotion) and cellular Ca 2+ -handling/contractile dysfunction (loss of Ca 2+ transient amplitude, sarcomere contractility). Finally, atrial tissue from patients with AF also showed a significant increase in HDAC6 activity and reduction in the expression of both acetylated and total α-tubulin. Conclusions—: AF induces remodeling and loss of contractile function, at least in part through HDAC6 activation and subsequent derailment of α-tubulin proteostasis and disruption of the cardiomyocyte microtubule structure. In vivo inhibition of HDAC6 protects against AF-related atrial remodeling, disclosing the potential of HDAC6 as a therapeutic target in clinical AF.

1 October 2006 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
SDSerkan Durdu
Serkan Durdu
AAAhmet Ruchan Akar
Ahmet Ruchan Akar
MAMutlu Arat
Mutlu Arat
TSTanzer Sancak
Tanzer Sancak
NENeyyir Tuncay Eren
Neyyir Tuncay Eren
UOUmit Ozyurda
Umit Ozyurda

11 November 2011 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
Cagdas BaranCagdas Baran
Cagdas Baran
SDSerkan Durdu
Serkan Durdu
KDKlara Dalva
Klara Dalva
ÇZÇagın Zaim
Çagın Zaim
ADArın Dogan
Arın Dogan
AAAhmet Ruchan Akar
Ahmet Ruchan Akar

15 October 2021 in Cardiovascular Therapeutics
Verified
Journal Article
Open access
PDF file
GDGünseli Çubukçuoğlu Deniz
Günseli Çubukçuoğlu Deniz
SDSerkan Durdu
Serkan Durdu
YDYeşim Doğan
Yeşim Doğan
EEEsra Erdemli
Esra Erdemli
HÖHilal Özdağ
Hilal Özdağ
AAAhmet Ruchan Akar
Ahmet Ruchan Akar
Objectives. Transcriptomics of atrial fibrillation (AFib) in the setting of chronic primary mitral regurgitation (MR) remains to be characterized. We aimed to compare the gene expression profiles of patients with degenerative MR in AFib and sinus rhythm (SR) for a clearer picture of AFib pathophysiology. Methods. After transcriptomic analysis and bioinformatics ( ), differentially expressed genes were defined using 1.5-fold change as the threshold. Additionally, independent datasets from GEO were included as meta-analyses. Results. QRT-PCR analysis confirmed that AFib persistence was associated with increased expression molecular changes underlying a transition to heart failure (NPPB, ; ANGPTL2, ; IGFBP2, ), structural remodeling including changes in the extracellular matrix and cellular stress response (COLQ, ; COMP, ; DHRS9, ; CHGB, ), and cellular stress response (DNAJA4, ). Furthermore, AFib persistence was associated with decreased expression of the targets of structural remodeling (BMP7, ) and electrical remodeling (CACNB2, ; MCOLN3, ) in both left and right atrial samples. The transmission electron microscopic analysis confirmed ultrastructural atrial remodeling and autophagy in human AFib atrial samples. Conclusions. Atrial cardiomyocyte remodeling in persistent AFib is closely linked to alterations in gene expression profiles compared to SR in patients with primary MR. Study findings may lead to novel therapeutic targets. This trial is registered with ClinicalTrials.gov identifier: NCT00970034.

1 September 2003 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
MSMustafa Sirlak
Mustafa Sirlak
SESadik Eryilmaz
Sadik Eryilmaz
LYLevent Yazicioglu
Levent Yazicioglu
UKUgursay Kiziltepe
Ugursay Kiziltepe
ZEZeynep Eyileten
Zeynep Eyileten
HAHakki Akalin
Hakki Akalin

15 September 2012 in Cardiovascular Therapeutics
Verified
Journal Article
Open access
PDF file
SDSerkan Durdu
Serkan Durdu
GDGünseli Çubukçuoğlu Deniz
Günseli Çubukçuoğlu Deniz
DBDeniz Balci
Deniz Balci
CZCagin Zaim
Cagin Zaim
ADArin Dogan
Arin Dogan
AAAhmet Ruchan Akar
Ahmet Ruchan Akar
Summary: Aims: This study investigates the expression patterns of BCL2 (B‐cell CLL/lymphoma2) family of proteins and the extent of vascular smooth muscle cell (VSMC) apoptosis in thoracic aortic aneurysms (TAA), type‐A aortic dissections (TAD), and nondilated ascending aortic samples. Methods: Aortic wall specimens were obtained from patients undergoing surgical repair for TAA (n = 24), TAD (n = 20), and normal aortic tissues from organ donors (n = 6). The expression pattern of BCL2, BCL2L1 (BCL2‐like1), BAK1 (BCL2‐antagonist/killer1), and BAX (BCL2‐associated X protein) proteins was investigated by immunohistochemistry. Furthermore, colocalization of alpha smooth muscle actin (ACTA2) and caspase3 (CASP3) in aortic VSMCs was analyzed by double‐immunofluorescence staining. Onset of DNA fragmentation was measured by TUNEL assay. Results: Apoptotic index was significantly increased in both TAD group (31.3 ± 17.2, P < 0.001) and TAA group (21.1 ± 12.7, P = 0.001) relative to control aortas (2.0 ± 1.2). Anti‐CASP3 and ACTA2 double‐immunostaining confirmed apoptosis in VSMCs in TAA and TAD groups but not in controls. Proapoptotic BAX expression was significantly elevated in VSMCs of TAA patients, compared with that of controls (OR = 20; P = 0.02; 95% CI, 16–250). In contrast, antiapoptotic BCL2L1 expression was higher in controls compared with that of TAA group (OR = 11.2; P = 0.049; 95% CI, 1.0–123.9). Furthermore, BAX/BCL2 ratio was significantly increased in both TAA (1.2 ± 0.7, P < 0.001) and TAD (0.6 ± 0.4, P = 0.05) groups relative to controls (0.2 ± 0.1, P < 0.001). Conclusions: Apoptotic VSMC depletion in human TAA/TAD is associated with disturbance of the balance between proapoptotic and antiapoptotic members of the BCL2 family proteins, which may have a role in the pathogenesis of vascular remodelling in aortic disease. In light of the future studies, targeting apoptotic pathways in TAA and TAD pathogenesis may provide therapeutic benefits to patients by slowing down the progression and even possibly preventing the TAD.